D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.14% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 10.3% |
| 4 | Financials | 9.14% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNBC
3426
DELISTED
Green Bancorp, Inc
GNBC
| $243K | ﹤0.01% |
+11,247
| New | +$258K |
|
3427
Civista Bancshares
CIVB
$594M
| $242K | ﹤0.01% |
+9,969
| New | +$238K |
|
3428
Independent Bank
INDB
$4.05B
| $242K | ﹤0.01% |
3,088
-2,670
| -46% | -$204K |
|
3429
PUT
Lindsay Corp
LNN
$1.16B
| $242K | ﹤0.01% |
+2,500
| New | +$235K |
|
|
AXE
3430
PUT
DELISTED
Anixter International Inc
AXE
| $241K | ﹤0.01% |
+3,800
| New | +$254K |
|
|
FPRX
3431
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $240K | ﹤0.01% |
+15,157
| New | +$264K |
|
3432
Live Oak Bancshares
LOB
$1.95B
| $239K | ﹤0.01% |
7,794
-8,348
| -52% | -$245K |
|
3433
PUT
Zoetis
ZTS
$31.6B
| $239K | ﹤0.01% |
2,800
-900
| -24% | -$76K |
|
|
TRTN
3434
DELISTED
Triton International Limited
TRTN
| $239K | ﹤0.01% |
7,780
-7,971
| -51% | -$264K |
|
|
IMH
3435
CALL
DELISTED
Impac Mortgage Holdings Inc.
IMH
| $238K | ﹤0.01% |
25,000
| – | – |
|
3436
CALL
Avis
CAR
$5.63B
| $237K | ﹤0.01% |
7,300
-171,700
| -96% | -$7.48M |
|
3437
Sturm, Ruger & Co
RGR
$610M
| $237K | ﹤0.01% |
4,229
-19,013
| -82% | -$1.11M |
|
3438
International Seaways
INSW
$4.57B
| $235K | ﹤0.01% |
10,157
-7,825
| -44% | -$158K |
|
3439
Primis Financial Corp
FRST
$382M
| $234K | ﹤0.01% |
+13,110
| New | +$220K |
|
|
XEC
3440
CALL
DELISTED
CIMAREX ENERGY CO
XEC
| $234K | ﹤0.01% |
+2,300
| New | +$218K |
|
3441
CALL
MSCI
MSCI
$40B
| $232K | ﹤0.01% |
+1,400
| New | +$221K |
|
|
VSA
3442
VisionSys AI
VSA
$9.61M
| $232K | ﹤0.01% |
12
-2
| -14% | -$47.4K |
|
|
AZPN
3443
CALL
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $232K | ﹤0.01% |
+2,500
| New | +$232K |
|
3444
CALL
Baker Hughes
BKR
$56.8B
| $231K | ﹤0.01% |
+7,000
| New | +$238K |
|
3445
VYNE Therapeutics
VYNE
$340K
| $231K | ﹤0.01% |
+395
| New | +$307K |
|
3446
KRONOS Worldwide
KRO
$761M
| $230K | ﹤0.01% |
+10,211
| New | +$243K |
|
3447
Clearway Energy Class C
CWEN
$5B
| $229K | ﹤0.01% |
13,332
-6,542
| -33% | -$115K |
|
3448
SLM Corp
SLM
$4.57B
| $229K | ﹤0.01% |
20,000
-60,261
| -75% | -$697K |
|
3449
Weis Markets
WMK
$1.82B
| $229K | ﹤0.01% |
+4,285
| New | +$212K |
|
|
ATRI
3450
DELISTED
Atrion Corp
ATRI
| $229K | ﹤0.01% |
382
-89
| -19% | -$53.5K |
|
Similar funds
D.E. Shaw & Co's Q2 2018 Portfolio in Review
As of Q2 2018, D.E. Shaw & Co held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- D.E. Shaw & Co added most to Amazon in Q2 2018, an estimated $696M increase.
- D.E. Shaw & Co's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- D.E. Shaw & Co fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- D.E. Shaw & Co opened 622 new positions and closed 399 in Q2 2018.
- D.E. Shaw & Co's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.